Seer Inc (SEER)
2.42
+0.10
(+4.40%)
USD |
NASDAQ |
Nov 14, 16:00
2.42
0.00 (0.00%)
After-Hours: 16:55
Seer Gross Profit Margin (Quarterly): 46.88% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 46.88% |
| June 30, 2024 | 55.68% |
| March 31, 2024 | 43.73% |
| December 31, 2023 | 41.70% |
| September 30, 2023 | 47.40% |
| June 30, 2023 | 50.23% |
| March 31, 2023 | 46.61% |
| Date | Value |
|---|---|
| December 31, 2022 | 40.17% |
| September 30, 2022 | 49.18% |
| June 30, 2022 | 43.66% |
| March 31, 2022 | 37.30% |
| December 31, 2021 | 46.14% |
| September 30, 2021 | 54.03% |
| June 30, 2021 | 51.85% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
37.30%
Minimum
Mar 2022
55.68%
Maximum
Jun 2024
46.75%
Average
46.75%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Organogenesis Holdings Inc | 77.58% |
| Poseida Therapeutics Inc | -- |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 84.00% |
| IGC Pharma Inc | 59.93% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -21.80% |
| Return on Assets | -19.74% |
| Return on Invested Capital | -21.80% |
| Profit Margin (Quarterly) | -541.0% |
| Operating Margin (Quarterly) | -617.1% |
| Return on Net Operating Assets | -142.1% |